CRF Receptor
The neuropeptide corticotropin-releasing factor (CRF) and its relatives, the urocortins 1–3, in concert with their receptors (CRFR1, CRFR2), have emerged as central components of the physiological stress response. The CRFR1 and CRFR2 belong to the secretin-like family, also known as class B1, of G protein-coupled receptors (GPCRs). Several endogenous hormones mediate their responses through the CRF receptors, such as CRF and the urocortins. The structures for the N-terminus extracellular domain of both CRF1R and CRF2R in complex with peptidic ligands were released and permitted the study of hormone binding to the orthosteric binding site. Stimulation of CRFRs in cultures of primary pituitary cells leads to activation of Gs and elicits a cAMP response, most physiological functions of CRF/CRFR1 have been assigned to Gs coupling.
CRFRs have the competence to couple to different G proteins, enabling them to activate a broad spectrum of downstream signaling pathways. CREB phosphorylation plays no role; instead the activation of PKA via CRF and cAMP stimulates two parallel signal transduction pathways. One signaling pathway is calcium dependent and involves the CaMKII. The other is calcium independent. In addition, CRF binding to CRFR1 activates the MAP kinase signaling pathway, which involves the small G proteins Rap1 and B-Raf, as well as the MAP kinases MEK and ERK1/2. This signal cascade leads to phosphorylation and activation of Nur77 (FIGURE 12). Ultimately, these different signaling pathways regulate the expression of POMC, from which ACTH is liberated by proteolytic processing.
References
1.Deussing JM,et al. Physiol Rev. 2018 Oct 1;98(4):2225-2286.
CRFRs have the competence to couple to different G proteins, enabling them to activate a broad spectrum of downstream signaling pathways. CREB phosphorylation plays no role; instead the activation of PKA via CRF and cAMP stimulates two parallel signal transduction pathways. One signaling pathway is calcium dependent and involves the CaMKII. The other is calcium independent. In addition, CRF binding to CRFR1 activates the MAP kinase signaling pathway, which involves the small G proteins Rap1 and B-Raf, as well as the MAP kinases MEK and ERK1/2. This signal cascade leads to phosphorylation and activation of Nur77 (FIGURE 12). Ultimately, these different signaling pathways regulate the expression of POMC, from which ACTH is liberated by proteolytic processing.
References
1.Deussing JM,et al. Physiol Rev. 2018 Oct 1;98(4):2225-2286.
GPCR/G Protein
ACAT(3)
Angiotensin Receptor(27)
Antibacterial(471)
Bombesin Receptor(11)
Bradykinin Receptor(18)
Calcium Channel(137)
cAMP(9)
Cannabinoid Receptor(69)
CaSR(17)
CGRP Receptor(14)
Chemokine Receptor(104)
Cholecystokinin Receptor(17)
CRF Receptor(13)
Dopamine Receptor(145)
Endothelin Receptor(20)
FFAR(5)
Galanin Receptor(1)
GHSR(16)
Glucagon Receptor(36)
GPCR19(7)
GPR119(3)
Hedgehog (Hh)(27)
Histamine Receptor(110)
Imidazoline Receptor(1)
Leukotriene Receptor(9)
LHR(1)
LPA Receptor(12)
Lysophospholipid Receptor(13)
mAChR(25)
MCHR(6)
Melanocortin Receptor(22)
Melatonin Receptor(5)
mGluR(11)
Motilin Receptor(4)
Neurokinin Receptor(34)
Neuropeptide Y Receptor(36)
Neurotensin Receptor(8)
Orexin Receptor(14)
Other Targets(3)
OXTR(2)
P2Y Receptor(8)
PAR(24)
Platelet-activating Factor Receptor(2)
Prostaglandin Receptor(60)
PTH Receptor(1)
S1P Receptor(22)
SGLT(22)
Somatostatin Receptor(11)
Urotensin Receptor(4)
Vasopressin Receptor(16)
CRF Receptor
-
Sauvagine
catalog no : M30802
cas no: 74434-59-6
Corticotropin-releasing factor (CRF) receptor agonist. Ki values are 9.4, 9.9, and 3.8 nM for inhibition of 125I-[D-Tyr1]astressin binding to hCRF-R1, rCRF-R2a and mCRF-R2b respectively. -
Antisauvagine-30
catalog no : M30763
cas no: 220673-95-0
Potent, selective and competitive corticotropin-releasing factor CRF2 receptor antagonist (Kd values are 1.4 and 153.6 nM for binding to mouse CRF2β and rat CRF1 receptors respectively). Inhibits sauvagine-stimulated cAMP accumulation in HEK-mCRF2β cells (pA2 = 8.49). Prevents stress-enhanced fear conditioning and MEK 1/2-dependent activation of ERK1/2 in mice in vivo. -
α-helical CRF 9-41
catalog no : M30712
cas no: 90880-23-2
Corticotropin-releasing factor receptor antagonist (Ki values are 17, 5 and 0.97 at human CRF1, rat CRF2α and mouse CRF2β receptors respectively). -
CRF (6-33)
catalog no : M30711
cas no: 120066-38-8
Corticotropin-releasing factor binding protein (CRFBP) inhibitor peptide; displaces CRF from CRFBP. Suppresses body weight gain and increases motor activity in obese rats in vivo. -
K 41498
catalog no : M30654
cas no: 434938-41-7
Potent and highly selective CRF2 receptor antagonist (Ki values are 0.66, 0.62 and 425 nM for human CRF2α, CRF2β and CRF1 receptors respectively). Inhibits sauvagine-stimulated cAMP accumulation in hCRF2α- and hCRF2β-expressing cells. In rats in vivo, blocks urocortin-induced hypotension following systemic administration.